Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study-Reference-Cited by-同舟云学术

Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study

Published:2024-06 Issue: Volume:41 Page:100912
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Iacovino Maria Lucia,Celant Simone,Tomassini Luca,Arenare Laura,Caglio Andrea,Canciello Andrea,Salerno Flavio,Olimpieri Pier Paolo^ORCID,Di Segni Susanna,Sferrazza Antonella,Piccirillo Maria Carmela,Beretta Giordano Domenico^ORCID,Pinto Carmine^ORCID,Blasi Livio,Cinieri Saverio,Cavanna Luigi,Di Maio Massimo,Russo Pierluigi,Perrone Francesco^ORCID

Funder

Ministero della Salute

Publisher

Elsevier BV

Reference28 articles.

1. Clinical trial endpoints for the approval of cancer drugs and biologics guidance for industry,2018

2. Participation in cancer clinical trials: race-, sex-, and age-based disparities;Murthy;JAMA,2004

3. Under-representation of older adults in cancer registration trials: known problem, little progress;Scher;J Clin Oncol,2012

4. Broadening eligibility criteria to make clinical trials more representative: American society of clinical oncology and friends of cancer research joint research statement;Kim;J Clin Oncol,2017

5. Increasing inclusiveness of patient-centric clinical evidence generation in oncology: real-world data and clinical trials;Benbow;Am Soc Clin Oncol Educ Book,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling the Cardiovascular Toxicities of CDK4/6 Inhibitors: A Real-World Pharmacovigilance Study;Cancers;2024-08-17